Filing Details
- Accession Number:
- 0001209191-19-010799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-15 20:16:30
- Reporting Period:
- 2019-02-15
- Accepted Time:
- 2019-02-15 20:16:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678248 | Wayne Michael Kalb | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | Svp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2019-02-15 | 25,000 | $17.58 | 20,551 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.36 to $17.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Please see the section titled "Remarks" below for additional information.